Table 1.
Subject characteristics
| Control (n = 8) | HFrEF (n = 8) | |
|---|---|---|
| Age, yr | 63 ± 2 | 63 ± 4 |
| Height, cm | 174 ± 4 | 174 ± 3 |
| Weight, kg | 76 ± 7 | 82 ± 4 |
| Body mass index, kg/m2 | 26 ± 1 | 27 ± 1 |
| Thigh volume, liters | 7.7 ± 0.5 | 5.9 ± 0.1* |
| Quadriceps muscle mass, kg | 2.7 ± 0.1 | 2.2 ± 0.0* |
| Systolic blood pressure, mmHg | 120 ± 3 | 120 ± 6 |
| Diastolic blood pressure, mmHg | 79 ± 2 | 77 ± 3 |
| MAP, mmHg | 93 ± 3 | 91 ± 4 |
| KEmax, W | 33 ± 6 | 18 ± 2* |
| Glucose, mg/dl | 86 ± 4 | 99 ± 8 |
| Total cholesterol, mg/dl | 195 ± 14 | 139 ± 19* |
| Triglycerides, mg/dl | 117 ± 24 | 103 ± 10 |
| HDL, mg/dl | 47 ± 4 | 37 ± 3 |
| LDL, mg/dl | 131 ± 13 | 86 ± 15* |
Values are means ± SE; n = number of subjects. HFrEF, heart failure with reduced ejection fraction; MAP, mean arterial pressure; KEmax, maximum knee-extensor exercise; HDL, high-density lipoprotein; LDL, low-density lipoprotein.
*
P < 0.05 vs. control.